Securities code: Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) securities abbreviation: Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) Announcement No.: 2022019 bond Code: 113585 bond abbreviation: Shouxian convertible bond
Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896)
Announcement on the general election of the board of supervisors
The board of supervisors and all supervisors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) (hereinafter referred to as “the company”) the term of office of the second board of supervisors is about to expire. According to the company law, the securities law, the Listing Rules of Shanghai Stock Exchange and other laws and regulations, normative documents and the relevant provisions of the articles of association, the company shall conduct the general election of the board of supervisors in accordance with the procedures. The general election of the board of supervisors is hereby announced as follows:
The third board of supervisors of the company consists of three supervisors, including two non employee representative supervisors and one employee representative supervisor. The company held the 22nd Meeting of the third board of supervisors on March 31, 2022, deliberated and adopted the proposal on the election of non employee representative supervisors of the Fourth Board of supervisors, and agreed to nominate Ms. Xu Lingyan and Ms. Hu Lingjuan as candidates for non employee representative supervisors of the Fourth Board of supervisors of the company (resume attached). The above proposals need to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation. The election of non employee representative supervisors will be conducted in the form of cumulative voting system. The supervisor of the Fourth Board of supervisors of the company will take office from the date of deliberation and approval by the general meeting of shareholders for a term of three years. The employee representative supervisors will be elected by the employee representative meeting of the company and form the Fourth Board of supervisors of the company together with the two non employee representative supervisors elected by the annual general meeting of shareholders of the company in 2021. Their term of office is the same as that of non employee representative supervisors. Before the new board of supervisors is elected by the general meeting of shareholders, the third board of supervisors of the company will continue to perform its duties.
It is hereby announced.
Attachment: resume of non employee representative supervisor candidates of the Fourth Board of supervisors
Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) board of supervisors April 1, 2022
Attachment: resume of non employee representative supervisor candidates of the Fourth Board of supervisors
Ms. Xu Lingyan, born in 1987, Chinese nationality, without permanent residency abroad, with a bachelor’s degree. He joined Jinhua Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) Pharmaceutical Co., Ltd. in August 2009, once served as QA, administrative Commissioner and R & D member, and now serves as the director of manufacturing department.
Ms. Hu Lingjuan, born in 1987, Chinese nationality, without permanent overseas residency, bachelor degree. He has worked in Zhejiang DINGLONG Chemical Co., Ltd. and Hangzhou wonderful Chemical Co., Ltd. since August 2009. In October 2011, he joined Wuyi Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) traditional Chinese medicine decoction Co., Ltd. and is now the supervisor of the company and the director of food R & D department.
